HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ching-Shih Chen Selected Research
Ching-Shih Chen Research Topics
Disease
104
Neoplasms (Cancer)
01/2020 - 09/2002
39
Prostatic Neoplasms (Prostate Cancer)
05/2019 - 04/2002
20
Breast Neoplasms (Breast Cancer)
01/2020 - 01/2005
15
Carcinogenesis
12/2015 - 06/2004
7
Neoplasm Metastasis (Metastasis)
01/2018 - 11/2009
7
Hepatocellular Carcinoma (Hepatoma)
03/2014 - 10/2007
6
Pancreatic Neoplasms (Pancreatic Cancer)
04/2019 - 02/2006
6
Triple Negative Breast Neoplasms
11/2017 - 11/2011
6
Multiple Myeloma
01/2014 - 08/2007
5
Adenocarcinoma
03/2013 - 10/2005
4
Inflammation (Inflammations)
07/2018 - 06/2011
4
Lymphoma (Lymphomas)
04/2016 - 01/2008
4
Thyroid Neoplasms (Thyroid Cancer)
01/2016 - 11/2007
4
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2014 - 01/2008
4
Starvation
03/2013 - 09/2008
4
B-Cell Lymphoma (Lymphoma, B Cell)
03/2009 - 03/2005
3
Body Weight (Weight, Body)
01/2020 - 12/2014
3
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2015 - 06/2010
3
Hypoxia (Hypoxemia)
04/2015 - 11/2011
3
Glioma (Gliomas)
05/2014 - 08/2006
3
Glioblastoma (Glioblastoma Multiforme)
05/2014 - 11/2005
3
Leukemia
12/2013 - 09/2007
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2013 - 05/2005
3
Acoustic Neuroma (Acoustic Neurinoma)
01/2012 - 06/2009
3
Lung Neoplasms (Lung Cancer)
01/2012 - 04/2006
2
Cachexia
01/2020 - 12/2015
2
Squamous Cell Carcinoma of Head and Neck
07/2018 - 06/2012
2
Melanoma (Melanoma, Malignant)
01/2016 - 04/2010
2
Liver Neoplasms (Liver Cancer)
12/2015 - 03/2014
Drug/Important Bio-Agent (IBA)
31
Histone Deacetylase Inhibitors
IBA
01/2020 - 10/2004
23
Celecoxib (Celebrex)
FDA Link
04/2019 - 04/2002
18
Histone Deacetylases (Histone Deacetylase)
IBA
11/2017 - 08/2005
18
Proteins (Proteins, Gene)
FDA Link
03/2016 - 05/2005
15
Phosphotransferases (Kinase)
IBA
03/2016 - 06/2004
13
OSU 03012
IBA
04/2019 - 02/2006
11
Histones (Histone)
IBA
12/2016 - 01/2004
11
PPAR gamma
IBA
03/2010 - 02/2005
9
Phosphatidylinositols (Phosphatidylinositol)
IBA
04/2019 - 07/2003
9
Biomarkers (Surrogate Marker)
IBA
11/2017 - 08/2007
9
Fingolimod Hydrochloride (FTY720)
FDA Link
09/2015 - 09/2007
8
integrin-linked kinase
IBA
11/2018 - 09/2011
6
Protein Kinases (Protein Kinase)
IBA
04/2019 - 04/2008
6
Antineoplastic Agents (Antineoplastics)
IBA
11/2015 - 11/2005
6
Glucose (Dextrose)
FDA Link
Generic
10/2014 - 09/2008
6
Cyclin D1
IBA
12/2011 - 04/2005
6
Troglitazone (Rezulin)
FDA Link
04/2009 - 04/2005
6
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
08/2007 - 04/2002
5
Androgens
IBA
01/2020 - 04/2002
5
Androgen Receptors (Androgen Receptor)
IBA
01/2020 - 04/2007
5
ErbB Receptors (EGF Receptor)
IBA
04/2016 - 01/2005
5
Messenger RNA (mRNA)
IBA
12/2015 - 10/2005
5
2,4-thiazolidinedione (thiazolidinedione)
IBA
11/2015 - 05/2006
5
indole-3-carbinol
IBA
05/2010 - 08/2007
5
Thiazolidinediones
IBA
07/2009 - 03/2005
4
Protein Isoforms (Isoforms)
IBA
11/2017 - 12/2012
4
Small Interfering RNA (siRNA)
IBA
04/2016 - 01/2014
4
DNA (Deoxyribonucleic Acid)
IBA
04/2014 - 06/2007
4
Deoxyglucose (2 Deoxy D glucose)
IBA
12/2012 - 03/2010
4
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2012 - 07/2003
4
Lenalidomide (CC 5013)
FDA Link
09/2011 - 05/2008
4
Vorinostat
FDA Link
01/2011 - 09/2006
4
NF-kappa B (NF-kB)
IBA
05/2010 - 04/2008
4
ciglitazone
IBA
03/2010 - 04/2005
3
Gemcitabine
FDA Link
04/2019 - 02/2006
3
Estrogen Receptors
IBA
04/2019 - 04/2008
3
Oxygen (Dioxygen)
IBA
10/2018 - 01/2014
3
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
01/2018 - 11/2006
3
OSU-53
IBA
01/2016 - 11/2011
3
Integrins
IBA
12/2015 - 01/2012
3
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
11/2015 - 03/2015
3
Tensins
IBA
11/2015 - 05/2006
3
Adenosine Monophosphate (AMP)
IBA
11/2015 - 11/2011
3
OSU-2S
IBA
09/2015 - 06/2011
3
Luciferases
IBA
06/2015 - 11/2009
3
Hormones (Hormone)
IBA
03/2015 - 06/2012
3
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
01/2012 - 09/2007
3
benzamide
IBA
01/2012 - 07/2008
3
beta Catenin
IBA
01/2010 - 09/2007
3
(1- (4- chloro- 3- nitrobenzenesulfonyl)- 1H- indol- 3- yl)- methanol
IBA
11/2009 - 08/2007
3
Succinic Acid (Succinate)
IBA
09/2009 - 04/2006
3
beta-Transducin Repeat-Containing Proteins
IBA
07/2009 - 09/2007
3
Survivin
IBA
10/2007 - 05/2006
3
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
05/2006 - 04/2002
2
Notch1 Receptor
IBA
01/2020 - 01/2016
2
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
04/2019 - 10/2014
2
Tamoxifen
FDA Link
Generic
04/2019 - 04/2008
2
Enzymes
IBA
07/2018 - 10/2009
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2018 - 09/2015
2
Estrogens (Estrogen)
FDA Link
04/2016 - 04/2008
2
Endoplasmic Reticulum Chaperone BiP
IBA
03/2016 - 02/2012
2
Cytokines
IBA
01/2016 - 12/2015
2
OSU-CG5
IBA
12/2015 - 03/2013
2
Ligases (Synthetase)
IBA
12/2015 - 04/2014
2
Trastuzumab (Herceptin)
FDA Link
11/2015 - 11/2006
2
Interleukin-6 (Interleukin 6)
IBA
06/2015 - 11/2011
2
TOR Serine-Threonine Kinases
IBA
05/2015 - 01/2010
Therapy/Procedure
36
Therapeutics
01/2020 - 06/2004
7
Drug Therapy (Chemotherapy)
10/2016 - 05/2006
6
Oral Administration
12/2016 - 10/2007
2
Radiotherapy
10/2018 - 02/2012